Our Early Development Services group is committed to the highest standards of clinical excellence and scientific expertise.
We operate state-of-the-art clinical research centres in The Netherlands and North America as well as an innovative patient pharmacology model in Central and Eastern Europe, providing the biopharmaceutical industry with a unique scientific environment required for complex compound development and testing.